159938 医药
已收盘 08-16 15:00:00
资讯
新帖
简况
V观财报|片仔癀二季度净利下滑,医药制造业毛利率明显下降
中新经纬 · 08-16 20:00
V观财报|片仔癀二季度净利下滑,医药制造业毛利率明显下降
海泰新光(688677):医药/必需消费受库存影响业绩承压 下半年有望改善
国泰君安证券股... · 08-16 18:39
海泰新光(688677):医药/必需消费受库存影响业绩承压 下半年有望改善
IPO要闻汇 | 审2过2,先锋精科首发过会,同源康医药下周登陆港交所
财经网 · 08-16 18:20
IPO要闻汇 | 审2过2,先锋精科首发过会,同源康医药下周登陆港交所
百克生物:8月16日接受机构调研,中信医药、国信医药等多家机构参与
证星公司调研 · 08-16 17:04
百克生物:8月16日接受机构调研,中信医药、国信医药等多家机构参与
【A股午评:沪指微涨0.09% AI眼镜概念再度走强】金十数据8月16日讯,A股三大指数早盘窄幅震荡,截至午间收盘,上证指数涨0.
美港电讯 · 08-16 11:37
【A股午评:沪指微涨0.09% AI眼镜概念再度走强】金十数据8月16日讯,A股三大指数早盘窄幅震荡,截至午间收盘,上证指数涨0.
A股医药板块震荡反弹,海辰药业涨超15%,上海谊众、亚太药业、广生堂、浙江医药、海南海药、普利制药等跟涨。
美港电讯 · 08-16 09:59
A股医药板块震荡反弹,海辰药业涨超15%,上海谊众、亚太药业、广生堂、浙江医药、海南海药、普利制药等跟涨。
华东医药(000963.SZ)与韩国IMB强强联手!医药老大哥再添两款自免创新药
智通财经 · 08-16 08:30
华东医药(000963.SZ)与韩国IMB强强联手!医药老大哥再添两款自免创新药
时隔14年,500亿医药白马宣布,中期分红!
中国基金报 · 08-16 07:51
时隔14年,500亿医药白马宣布,中期分红!
万春医药上涨2.19%,报1.86美元/股
金融界 · 08-15 23:18
万春医药上涨2.19%,报1.86美元/股
礼新医药公布C轮融资,投资方为上海生物医药基金、张江浩珩等
证券之星 · 08-15 19:30
礼新医药公布C轮融资,投资方为上海生物医药基金、张江浩珩等
瑞初医药公布Pre-A+轮融资,投资方为高科新浚
证券之星 · 08-15 19:29
瑞初医药公布Pre-A+轮融资,投资方为高科新浚
港股收盘(08.15) | 恒指微跌0.02% 科网股表现疲软 煤炭、医药、金融股等活跃
智通财经网 · 08-15 16:43
港股收盘(08.15) | 恒指微跌0.02% 科网股表现疲软 煤炭、医药、金融股等活跃
【浙商医药||孙建】诺禾致源24H1:国内稳步恢复,海外拓展持续
杏林建研 · 08-15 16:42
【浙商医药||孙建】诺禾致源24H1:国内稳步恢复,海外拓展持续
8月15日诚益通涨6.10%,银河医药混合A基金重仓该股
证券之星 · 08-15 16:11
8月15日诚益通涨6.10%,银河医药混合A基金重仓该股
【沃森生物新冠疫苗价格闹“乌龙”:前日价格错误,实际并未降价】金十数据8月15日讯,安徽省医药集中采购平台8月15日最新公布的安徽省2024年新冠病毒疫苗及部分非免疫规划疫苗采购目录中,沃森生物的新型冠状病毒变异珠mRNA疫苗(OmicronXBB.
美港电讯 · 08-15 13:02
【沃森生物新冠疫苗价格闹“乌龙”:前日价格错误,实际并未降价】金十数据8月15日讯,安徽省医药集中采购平台8月15日最新公布的安徽省2024年新冠病毒疫苗及部分非免疫规划疫苗采购目录中,沃森生物的新型冠状病毒变异珠mRNA疫苗(OmicronXBB.
医药商业行业盘中拉升,润达医疗涨2.60%
自选股智能写手 · 08-15 10:31
医药商业行业盘中拉升,润达医疗涨2.60%
医药商业行业盘中跳水,南京医药平盘
自选股智能写手 · 08-15 09:36
医药商业行业盘中跳水,南京医药平盘
【东北医药刘宇腾】三友医疗(688085)深度报告:国内业绩拐点或至,海外有望进入加速发展阶段
东北证券研究所 · 08-15 08:55
【东北医药刘宇腾】三友医疗(688085)深度报告:国内业绩拐点或至,海外有望进入加速发展阶段
【方正医药】华纳药厂(688799):布局抑郁症原创新药与濒危药材人工替代,打造原料药制剂一体化综合平台
方正证券研究 · 08-15 08:30
【方正医药】华纳药厂(688799):布局抑郁症原创新药与濒危药材人工替代,打造原料药制剂一体化综合平台
天风证券:医药的相对优势已较为明显
港股那点事 · 08-15 08:20
天风证券:医药的相对优势已较为明显
暂无数据
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"159938","market":"SZ","secType":"STK","nameCN":"医药","latestPrice":0.565,"timestamp":1723791783000,"preClose":0.565,"halted":0,"volume":39906800,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"08-16 15:00:00","open":0.565,"high":0.566,"low":0.558,"amount":22447900,"amplitude":0.0142,"askPrice":0.566,"askSize":11238,"bidPrice":0.565,"bidSize":124,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":0.565,"symbolType":"fund","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":0.621,"lowLimit":0.509,"ibTradeSell":false,"ibTradeBuySell":true,"pbRate":0,"committee":0.09551,"marketValue":0,"floatMarketCap":0,"changeRate":0,"turnoverRate":0,"status":2,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-08-19。","discountRate":"0.00%","netWorth":"0.000"},"requestUrl":"/m/hq/s/159938/tweets","defaultTab":"tweets","newsList":[{"id":"2459021951","title":"V观财报|片仔癀二季度净利下滑,医药制造业毛利率明显下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2459021951","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459021951?lang=zh_cn&edition=full","pubTime":"2024-08-16 20:00","pubTimestamp":1723809654,"startTime":"0","endTime":"0","summary":"16日晚间,片仔癀披露2024年半年报,公司期内营收56.51亿元,同比增12%;归属于上...","market":"us","thumbnail":"http://www.jwview.com/jingwei/08-16/U1014P902T1D604209F10DT20240816200054.jpg","type":0,"news_type":0,"thumbnails":["http://www.jwview.com/jingwei/08-16/U1014P902T1D604209F10DT20240816200054.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.jwview.com/jingwei/html/08-16/604209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zxjw_stock","symbols":["600436","09939","159938"],"gpt_icon":0},{"id":"2459294057","title":"海泰新光(688677):医药/必需消费受库存影响业绩承压 下半年有望改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2459294057","media":"国泰君安证券股...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459294057?lang=zh_cn&edition=full","pubTime":"2024-08-16 18:39","pubTimestamp":1723804753,"startTime":"0","endTime":"0","summary":"受客户库存影响销售节奏放缓,下半年有望环比改善。2024H1内窥镜业务实现收入1.76 亿元,主要为史赛克为降低库存量,拿货节奏放缓,但环比提升10%,已有所改善。下半年随收入环比改善,费用率有望呈下降趋势。2024H2,针对史赛克,4mm宫腔镜有望量产;2.9mm 膀胱镜、3mm 小儿腹腔镜、开放手术外视镜亦有望持续开发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816183923959e82c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816183923959e82c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","688677","BK0251"],"gpt_icon":0},{"id":"2459916892","title":"IPO要闻汇 | 审2过2,先锋精科首发过会,同源康医药下周登陆港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=2459916892","media":"财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459916892?lang=zh_cn&edition=full","pubTime":"2024-08-16 18:20","pubTimestamp":1723803600,"startTime":"0","endTime":"0","summary":"据京沪深交易所披露,本周2家企业“迎考”,先锋精科、聚星科技首发上会获通过。下周,1只新股登陆港交所。两家公司上会迎考,先锋精科业绩可持续性获关注本周,有两家IPO企业上会接受检验,均顺利过会。其中,先锋精科拟登陆科创板,聚星科技拟登陆北交所。本周暂无IPO企业撤回申报材料。8月15日,万华禾香在河南证监局办理辅导备案登记,拟首次公开发行股票并上市,辅导券商为东方证券。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-08-16/doc-incivvwx7278055.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-08-16/doc-incivvwx7278055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","BK1161","09939","BK1574","BK1515"],"gpt_icon":0},{"id":"2459729828","title":"百克生物:8月16日接受机构调研,中信医药、国信医药等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2459729828","media":"证星公司调研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459729828?lang=zh_cn&edition=full","pubTime":"2024-08-16 17:04","pubTimestamp":1723799040,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年8月16日百克生物发布公告称公司于2024年8月16日接受机构调研,中信医药、国信医药、华安医药、华源医药、华福医药、民生医药、申万医药、西南医药、兴业医药、信达医药、中银医药、东北医药、中金公司、投资者、东方医药、方正医药、国海医药、国金医药、国联医药、国投医药、国盛医药参与。同时,公司也在研发重组带状疱疹疫苗,目前该项目已提交Pre-IND。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408161705219f30a50e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408161705219f30a50e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","688276","BK0239"],"gpt_icon":0},{"id":"2459253100","title":"【A股午评:沪指微涨0.09% AI眼镜概念再度走强】金十数据8月16日讯,A股三大指数早盘窄幅震荡,截至午间收盘,上证指数涨0.","url":"https://stock-news.laohu8.com/highlight/detail?id=2459253100","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459253100?lang=zh_cn&edition=full","pubTime":"2024-08-16 11:37","pubTimestamp":1723779476,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0042","BK0046","BK0108","BK1515","603458","300691","FXP","159938","000001.SH","300968","399001","BK0273","XPP","600322","000300.SH","BK0132","09939","510030","300584","300564","BK0088","000810","002370","161121","PCB","BK4211","000016.SH","399300","BK0013","BK1574","BK0186","09979","BK0164","BK1161","BK0214","CNmain","512550","BK0041","300642","399006","BK0201","BK0239","BK1148","159982","YXI","510050","BK0221","BK0126"],"gpt_icon":0},{"id":"2459231238","title":"A股医药板块震荡反弹,海辰药业涨超15%,上海谊众、亚太药业、广生堂、浙江医药、海南海药、普利制药等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2459231238","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459231238?lang=zh_cn&edition=full","pubTime":"2024-08-16 09:59","pubTimestamp":1723773542,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159982","688091","09939","BK0070","BK0191","BK0060","BK1161","000566","BK0146","BK0188","BK0028","BK0239","BK1574","600216","300630","BK1515","300436","BK0132","002370","159938","300584","399300"],"gpt_icon":0},{"id":"2459238696","title":"华东医药(000963.SZ)与韩国IMB强强联手!医药老大哥再添两款自免创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2459238696","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459238696?lang=zh_cn&edition=full","pubTime":"2024-08-16 08:30","pubTimestamp":1723768230,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,2024年8月15日,华东医药发布公告称,其全资子公司中美华东与韩国IMBiologics corp.签订了产品独家许可协议,获得IMB两款自身免疫领域的全球创新产品IMB-101及IMB-102在包含中国在内的 37个亚洲国家的独家许可,包括开发、注册、生产及商业化权益。公告显示,本次交易涉及IMB拥有的2款自身免疫领域全球创新生物制剂。华东医药表示,未来将继续以临床需求和患者为先,与国内外优秀的企","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1165107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","LU1969619763.USD","BK0183","BK0196","159992","LU2328871848.SGD","BK0132","09939","BK1515","000963","BK1574","BK0175","BK0188","BK0209","BK1161","159938","BK0187"],"gpt_icon":0},{"id":"2459280823","title":"时隔14年,500亿医药白马宣布,中期分红!","url":"https://stock-news.laohu8.com/highlight/detail?id=2459280823","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459280823?lang=zh_cn&edition=full","pubTime":"2024-08-16 07:51","pubTimestamp":1723765860,"startTime":"0","endTime":"0","summary":"业绩稳增之下,华东医药拟实施中期分红,分配方案为每10股派发现金3.5元,不转增不送红股。报告期内,华东医药的医药工业、医药商业、医美和工业微生物四大业务板块经营指标均保持稳健增长,经营质量及增长动能持续稳步提升。工业微生物方面,报告期内实现销售收入2.85亿元,较去年同期增长27.43%。而这也是公司自2010年以来,时隔14年再次中期分红。截至8月15日,公司最新市值为500亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":null,"url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656125285&idx=2&sn=d0ca80db2c7d3538cd74a2436732df56&chksm=8ad1e0f671d804c3b6464ebbb2f1ab2b0030f134195634c3b1a68c59bb086c6f45d94db026f1&scene=0#rd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzA5MDEzNjQwMA==&mid=2656125285&idx=2&sn=d0ca80db2c7d3538cd74a2436732df56&chksm=8ad1e0f671d804c3b6464ebbb2f1ab2b0030f134195634c3b1a68c59bb086c6f45d94db026f1&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1161","BK1574","159938","BK1515"],"gpt_icon":0},{"id":"2459471194","title":"万春医药上涨2.19%,报1.86美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459471194","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459471194?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:18","pubTimestamp":1723735084,"startTime":"0","endTime":"0","summary":"8月15日,万春医药(BYSI)盘中上涨2.19%,截至23:18,报1.86美元/股,成交4047.0美元。财务数据显示,截至2023年12月31日,万春医药收入总额175.1万美元,同比增长29.61%;归母净利润-2102.6万美元,同比增长36.82%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/08/15231842409480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK1161","159938","BK1574","09939","BK1515"],"gpt_icon":0},{"id":"2459428453","title":"礼新医药公布C轮融资,投资方为上海生物医药基金、张江浩珩等","url":"https://stock-news.laohu8.com/highlight/detail?id=2459428453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459428453?lang=zh_cn&edition=full","pubTime":"2024-08-15 19:30","pubTimestamp":1723721435,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP于8月11日公布的信息整理,礼新医药科技(上海)有限公司公布C轮融资,融资额未披露,参与投资的机构包括上海生物医药基金,张江浩珩,浦东资本,中国生物制药。礼新医药科技(上海)有限公司的历史融资如下:礼新医药是一家立足中国、面向全球的临床阶段创新药研发公司,由生物医药业界资深人士于2019年创立。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500039228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1604","159938","BK1164","09939","LU0640798160.USD","SG9999001226.SGD","SGXZ90724238.SGD","SG9999001051.SGD","BK1574","BK1161","160635","BK1515","BK1516","LU1115378108.SGD","LU2460026573.USD","00780","SG9999001093.SGD"],"gpt_icon":0},{"id":"2459428135","title":"瑞初医药公布Pre-A+轮融资,投资方为高科新浚","url":"https://stock-news.laohu8.com/highlight/detail?id=2459428135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459428135?lang=zh_cn&edition=full","pubTime":"2024-08-15 19:29","pubTimestamp":1723721345,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP于8月6日公布的信息整理,南京瑞初医药有限公司公布Pre-A+轮融资,融资额未披露,参与投资的机构包括高科新浚。南京瑞初医药有限公司的历史融资如下:瑞初医药创立于2021年6月,围绕未被满足的临床需求,以独特的视角致力于开发靶向衰老机制“First-in-class”药物,预防、治疗和逆转衰老及衰老相关疾病。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500039184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09939","159938","BK1574","BK1515","BK1161"],"gpt_icon":0},{"id":"2459106064","title":"港股收盘(08.15) | 恒指微跌0.02% 科网股表现疲软 煤炭、医药、金融股等活跃","url":"https://stock-news.laohu8.com/highlight/detail?id=2459106064","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459106064?lang=zh_cn&edition=full","pubTime":"2024-08-15 16:43","pubTimestamp":1723711435,"startTime":"0","endTime":"0","summary":"7月重磅经济数据出炉,港股早盘低开高走,恒科指一度涨超1%,午后涨幅逐步收窄,恒指及恒科指相继翻绿。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20240815/20240815164701_37677.png?x-oss-process=image/format,jpg/quality,Q_80","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240815/20240815164701_37677.png?x-oss-process=image/format,jpg/quality,Q_80"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1164641.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01810","159938","BK1515","HSI","HSTECH","161032","02833","09939","00700","YANG","BK1574","513600","09633","HHImain","BK1161","MCHmain","HSCEI","09868"],"gpt_icon":1},{"id":"2459030412","title":"【浙商医药||孙建】诺禾致源24H1:国内稳步恢复,海外拓展持续","url":"https://stock-news.laohu8.com/highlight/detail?id=2459030412","media":"杏林建研","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459030412?lang=zh_cn&edition=full","pubTime":"2024-08-15 16:42","pubTimestamp":1723711373,"startTime":"0","endTime":"0","summary":"2024H1国内收入稳步恢复,海外收入持续增长,我们认为,随着平台换代逐步完成、国内科研需求恢复以及海外渠道拓展,2024年收入增长有望加速。2023年受到平台切换、经济环境与竞争格局等多方面的影响,公司中国大陆收入同比下滑9.02%,2024H1公司国内收入4.96亿元,同比增长6.3%,恢复正增长。海外仍处于加速拓展期,销售费用或将持续上升,但规模效应下净利率有望维持较高水平。2024H1公司净利率8.25%,同比下降0.2pct,其中销售费用率19.62%,同比提升0.43pct。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815164359959ad43a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815164359959ad43a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","159938","688315","BK0221"],"gpt_icon":0},{"id":"2459414834","title":"8月15日诚益通涨6.10%,银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2459414834","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459414834?lang=zh_cn&edition=full","pubTime":"2024-08-15 16:11","pubTimestamp":1723709506,"startTime":"0","endTime":"0","summary":"证券之星消息,8月15日诚益通涨6.10%,收盘报11.48元,换手率8.04%,成交量20.81万手,成交额2.35亿元。重仓诚益通的公募基金请见下表:该股最近90天内共有2家机构给出评级,增持评级2家。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共6家,其中持有数量最多的公募基金为银河医药混合A。银河医药混合A目前规模为4.69亿元,最新净值0.4447,较上一交易日下跌1.7%,近一年下跌22.81%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081500031403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0130","BK1161","159938","300430","BK0225","BK1574","09939","BK0028","BK1515"],"gpt_icon":0},{"id":"2459249688","title":"【沃森生物新冠疫苗价格闹“乌龙”:前日价格错误,实际并未降价】金十数据8月15日讯,安徽省医药集中采购平台8月15日最新公布的安徽省2024年新冠病毒疫苗及部分非免疫规划疫苗采购目录中,沃森生物的新型冠状病毒变异珠mRNA疫苗(OmicronXBB.","url":"https://stock-news.laohu8.com/highlight/detail?id=2459249688","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459249688?lang=zh_cn&edition=full","pubTime":"2024-08-15 13:02","pubTimestamp":1723698178,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1161","BK1574","BK0077","BK1515","09939","300142","159646","BK0239","BK0046","BK0070","159938"],"gpt_icon":0},{"id":"2459946927","title":"医药商业行业盘中拉升,润达医疗涨2.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459946927","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459946927?lang=zh_cn&edition=full","pubTime":"2024-08-15 10:31","pubTimestamp":1723689108,"startTime":"0","endTime":"0","summary":"08月15日,医药商业行业盘中拉升,截至10点31分,医药商业行业整体指数上涨1.02%,报4551.590点。从个股上来看,该行业的成分股中,润达医疗涨2.60%,百洋医药、九州通、瑞康医药涨幅居前。从资金上来看,截止发稿,医药商业行业主力净流入为-1868.49万,其中瑞康医药受到资金热捧,主力净流入462.35万;拉长时间线来看,该板块近20日主力资金净流入-1.93亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081510314894200aac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081510314894200aac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","603108","BK0250"],"gpt_icon":0},{"id":"2459141468","title":"医药商业行业盘中跳水,南京医药平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2459141468","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459141468?lang=zh_cn&edition=full","pubTime":"2024-08-15 09:36","pubTimestamp":1723685764,"startTime":"0","endTime":"0","summary":"08月15日,医药商业行业盘中跳水,截至09点35分,医药商业行业整体指数下跌0.55%,报4495.600点。从个股上来看,该行业的成分股中,南京医药平盘,跌幅居前。从资金上来看,截止发稿,医药商业行业主力净流入为-1040.64万,其中大参林受到资金热捧,主力净流入92.78万;拉长时间线来看,该板块近20日主力资金净流入-1.93亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081509360496826428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081509360496826428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0209","BK0250","159938","600713"],"gpt_icon":0},{"id":"2459545043","title":"【东北医药刘宇腾】三友医疗(688085)深度报告:国内业绩拐点或至,海外有望进入加速发展阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2459545043","media":"东北证券研究所","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459545043?lang=zh_cn&edition=full","pubTime":"2024-08-15 08:55","pubTimestamp":1723683330,"startTime":"0","endTime":"0","summary":"骨科行业进入稳健扩张阶段,国产替代有望持续。我们认为,公司产品间协同效应有望持续加强,叠加三季度脊柱业务价格同比可比,公司业绩有望迎来拐点。公司业绩有望于Q3迎来拐点,维持“增持”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150926519599bf68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150926519599bf68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","BK0251","688085"],"gpt_icon":0},{"id":"2459445109","title":"【方正医药】华纳药厂(688799):布局抑郁症原创新药与濒危药材人工替代,打造原料药制剂一体化综合平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2459445109","media":"方正证券研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459445109?lang=zh_cn&edition=full","pubTime":"2024-08-15 08:30","pubTimestamp":1723681840,"startTime":"0","endTime":"0","summary":"本文来自方正证券研究所于2024年8月14日发布的报告《华纳药厂:布局抑郁症原创新药与濒危药材人工替代,打造原料药制剂一体化综合平台》,欲了解具体内容,请阅读报告原文。原创抗抑郁新药有望成为潜在BIC品种,分享百亿级市场空间。独家布局濒危动物药材人工替代品,抢占数十亿产业空间先机。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150842259f2be50b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408150842259f2be50b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159938","159992","BK0239","688799"],"gpt_icon":0},{"id":"2459591484","title":"天风证券:医药的相对优势已较为明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2459591484","media":"港股那点事","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459591484?lang=zh_cn&edition=full","pubTime":"2024-08-15 08:20","pubTimestamp":1723681200,"startTime":"0","endTime":"0","summary":"格隆汇8月15日|天风证券研报表示,1)当前整体板块调整相对较为充分,行业有望逐步进入正常阶段。从行业比较来看,医药行业更多的优势在于“人口老龄化加深+需求品质升级”趋势较为清晰,医药的相对优势已较为明显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-08-15/doc-incisrnk1831230.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-08-15/doc-incisrnk1831230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159938","09939","601162","BK1574","BK1161","BK1515","BK0276"],"gpt_icon":0}],"profile":{"ret":0,"stockEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.014},{"period":"3month","weight":-0.124},{"period":"6month","weight":-0.113},{"period":"1year","weight":-0.2031},{"period":"ytd","weight":-0.1917}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0282},{"period":"3month","weight":-0.0871},{"period":"6month","weight":0.0047},{"period":"1year","weight":-0.0899},{"period":"ytd","weight":-0.0321}],"serverTime":1723864948833,"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"医药,159938,医药股票,医药股票老虎,医药股票老虎国际,医药行情,医药股票行情,医药股价,医药股市,医药股票价格,医药股票交易,医药股票购买,医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"医药(159938)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供医药(159938)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}